Robotic-assisted surgery for gastric cancer shows promise but access remains inequitable. Use of robotic surgery rose from 1.45% in 2010 to 26.57% in 2021, improving outcomes with shorter hospital stays and better survival rates. Key factors limiting access include older age, female sex, black race, uninsured status, and lower income. Surgeons should advocate for equitable […]
Category: Upper Gastrointestinal Tract
Innovative Treatments for Gastro-Oesophageal Reflux Disease
New approaches for managing gastro-oesophageal reflux disease (GORD) are evolving, impacting patient outcomes and surgical practices. Potassium-competitive acid blockers show higher healing rates and longer acid suppression than proton pump inhibitors. Robotic antireflux surgery yields outcomes comparable to traditional laparoscopic methods. Novel endoscopic techniques and devices are under evaluation, offering potential alternatives for patient treatment. […]
Enhanced Recovery Boosts Outcomes After Gastrectomy
Combining enhanced recovery after surgery (ERAS) nursing with early enteral nutrition significantly improves recovery for gastric cancer patients after radical gastrectomy. First flatus occurs 2.45 days vs. 3.84 days; first bowel movement 3.39 vs. 5.61 days. Hospital stay reduced: 8.75 days vs. 12.50 days. This approach also improves nutritional markers and lowers complication rates (6.25% […]
Postoperative CRP Predicts Survival in Gastric Cancer
Postoperative C-reactive protein levels are key indicators for survival outcomes in gastric cancer patients. Elevated CRP post-surgery correlates with increased mortality and recurrence risk (HR: 1.51 for OS, HR: 1.44 for RFS). CRP peak in the first week after surgery shows strong prognostic value, predicting worse outcomes (HR: 1.80 for OS, HR: 1.63 for RFS). […]
Glycemic Variability Predicts Postoperative Mortality in Gastric Surgery
Higher glycemic variability signals increased mortality risk in gastric surgery patients. Each 1% increase in glycemic variability raises 30-day mortality by 15% and 90-day mortality by 14%. Critical thresholds identified at glycemic variability levels of 20.24 for 30-day mortality and 33.96 for 90-day mortality. Monitoring and managing glycemic variability could significantly improve patient outcomes after […]
Treatment Choices for Esophageal Anastomotic Leak Matter
Endoscopic and surgical interventions significantly enhance outcomes for anastomotic leakage post-esophagectomy. Observation group had a 73% fistula closure rate versus 53% in the control group. Clinical treatment scores were higher at 3 months (5.67 vs. 4.73) and 6 months (8.33 vs. 6.27) for the observation group. These findings support early intervention to improve patient quality […]
New model predicts early recurrence risk in gastric cancer patients
A novel radiomics-based risk assessment model significantly improves prediction of early postoperative recurrence in locally advanced gastric cancer, crucial for surgical decision-making. AUC values range from 0.850 to 0.873 across multiple validation cohorts. The model outperforms traditional staging in predicting five-year overall survival (HR range: 1.830-2.166, p < 0.001). Enhanced immune infiltration in low-risk patients […]
Crural Stitch Technique Enhances Liver Retraction in Laparoscopy
Liver retraction can make or break laparoscopic upper GI surgeries; this new technique simplifies the process and cuts costs. In a study of 1,956 patients, the crural stitch method achieved effective liver retraction without complications. No hepatic injuries or infections were linked to the technique across various procedures like sleeve gastrectomy and gastric bypass. This […]
Fibrin Sealant Cuts Postoperative Complications in ESD
Applying human-derived fibrin sealant after gastric endoscopic submucosal dissection (ESD) significantly enhances patient outcomes. Delayed hemorrhage rates dropped to 1.7% in the fibrin group versus 6.9% in controls (p < 0.001). One month post-ESD, the fibrin group saw a wound healing rate of 65.4%, compared to 51.1% for controls (p = 0.014). This sealant not […]
Microbiome-Based Subtyping Boosts Esophageal Cancer Outcomes
Different tumor microbiomes in esophageal cancer patients directly impact survival rates. Patients with esophagotype A have 3-year overall survival rates of 73%, versus 57% for esophagotype B (p < 0.05). Recurrence-free survival is also better in esophagotype A at 80.7%, compared to 64% in esophagotype B. Understanding these microbiome signatures can help tailor treatment strategies […]